ClinicalTrials.Veeva

Menu

Respiratory Muscle Strength in Patients With Idiopathic Pulmonary Fibrosis

M

Medipol Health Group

Status

Completed

Conditions

Idiopathic Pulmonary Fibrosis

Treatments

Other: no intervention - cross-sectional observational only

Study type

Observational

Funder types

Other

Identifiers

NCT03588260
IPF_MIP/MEP

Details and patient eligibility

About

Respiratory muscle strength, dyspnea perception, physical activity and quality of life measurements will be performed and groups will be compared in two groups consisting of patients with idiopathic pulmonary fibrosis referred to pulmonary rehabilitation clinic and healthy volunteers in similar age range.

Full description

The patients who have agreed to participate in the study from patients diagnosed with idiopathic pulmonary fibrosis referred to the center of pulmonary rehabilitation from the interstitial lung disease polyclinic will be included in the study. In addition, a healthy adult control group will be established from similar age groups. The two groups will be compared in terms of outcome measures.The study outcome measurements are maximum inspiratory/expiratory muscle strength , international physical activity questionaire, modified Medical Research Council dyspnea scale, Short form 36 quality of lide questionaire, fatigue severity scale, six minute walking test.

Enrollment

60 patients

Sex

All

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Between the ages of 18-70
  • Patients signing informed consent form
  • Patients diagnosed with idiopathic pulmonary fibrosis.

Exclusion criteria

  • Patients who use steroids for less than 1 year
  • The patient does not want to participate in the study

Trial design

60 participants in 2 patient groups

Idiopathic pulmonary fibrosis
Description:
The patients who have agreed to participate in the study from patients diagnosed with idiopathic pulmonary fibrosis referred to the center of pulmonary rehabilitation from the interstitial lung disease polyclinic.
Treatment:
Other: no intervention - cross-sectional observational only
Healthy subjects
Description:
The healthy adults without additional disease
Treatment:
Other: no intervention - cross-sectional observational only

Trial contacts and locations

1

Loading...

Central trial contact

Arif Balcı; Esra Pehlivan, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems